TERN
Terns Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$52.95
−0.03%Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.30
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +10.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 14, 2026 | -$0.30 | -$0.26 | Beat 13.33% | — |
| May 8, 2025 | -$0.29 | -$0.26 | Beat 10.34% | — |
| Mar 20, 2025 | -$0.30 | -$0.24 | Beat 20.00% | — |
| Mar 14, 2024 | -$0.29 | -$0.29 | In line | $1.3M |
| Nov 14, 2023 | -$0.31 | -$0.42 | Miss -35.48% | — |
| May 15, 2023 | -$0.28 | -$0.31 | Miss -10.71% | — |
| Nov 9, 2022 | -$0.51 | -$0.44 | Beat 13.73% | — |
| May 16, 2022 | -$0.67 | -$0.55 | Beat 17.91% | — |
| Mar 3, 2022 | -$0.67 | -$0.56 | Beat 16.42% | $1.0M |
| Nov 15, 2021 | -$0.60 | -$0.47 | Beat 21.67% | — |
| Aug 16, 2021 | -$0.81 | -$0.43 | Beat 46.91% | — |
| May 13, 2021 | -$0.53 | -$0.88 | Miss -66.04% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 14, 2026